Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      Enhancing Clinical Research with Advanced Sensor Technology

      Clinical Trials
      Sensor technology is revolutionising clinical trials by delivering continuous, objective, and real-time health data that enhances patient monitoring, elevates data accuracy, and streamlines trial...

      FDA Approves Recombinant VWF Treatment in Pediatric Patients

      Drug Development
      The US Food and Drug Administration (FDA) has expanded the indication for recombinant von Willebrand factor (VWF), marketed as Vonvendi, to include children with...

      Novartis and Argo Signs Deal of up to $5.2b for Heart Drugs

      Drug Development
      Swiss pharmaceutical leader Novartis has entered into a cardiovascular drug licensing deal valued at up to $5.2 billion with China-based Argo Biopharmaceutical. The deal...

      Novartis and Arrowhead Sign Deal to Advance Parkinson’s Drug

      Drug Development
      Novartis has renewed its focus on Parkinson’s disease through a significant collaboration with Arrowhead Pharmaceuticals, marking another strategic step into neuroscience drug development. The...

      FDA Approves Eisai’s Leqembi IQLIK for Alzheimer’s Treatment

      Americas
      Eisai has achieved an important regulatory milestone as the FDA approves Leqembi IQLIK, strengthening the company’s long-term plans to expand the medicine’s use in...

      FDA Approves Sanofi’s Wayrilz for Immune Thrombocytopenia

      Americas
      The US FDA approves Sanofi’s Wayrilz (rilzabrutinib) for use in adult patients with chronic or persistent immune thrombocytopenia (ITP) who did not respond adequately...

      U.S. FDA Approves Ionis’ DAWNZERA for Hereditary Angioedema

      FDA Approvals
      Ionis Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted approval for DAWNZERA™ (donidalorsen). The treatment is approved for prophylaxis to...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.